CXCL17 and colonic neoplasm: CXCL17 overexpression increased the number of CD11b+/Gr-1+ myeloid-derived cells in colon tumor and was accompanied by enhanced tumorigenicity, implying that CXCL17 plays a tumor-promoting role by regulating immune cell recruitment [35].